All NIH Funding Opportunities and Notices

• Outstanding Mentors are Eligible for Presidential Awards for Excellence in Science, Mathematics and Engineering Mentoring (PAESMEM)
  (NOT-OD-13-069)
  National Institutes of Health
  

• Notice of Change in Personnel Cost Limit for RFA-OD-13-009 Short Courses on Innovative Methodologies in the Behavioral and Social Sciences
  (NOT-OD-13-070)
  Office of Behavioral and Social Sciences Research
  

• Reminder of Lobbying Prohibition on Federal Funds for All NIH-Supported Institutions
  (NOT-OD-13-072)
  National Institutes of Health
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Collaborative Research Infrastructure to Develop Research Strategies to Identify Potential Therapeutic Targets Based on Genetic Factors Influencing Human Life Span and Health Span (U24)
  (NOT-AG-13-012)
  National Institute on Aging
  

• Notice of Correction to PHS 398 Research Plan Instructions Announced in PAR-13-148 Limited Competition: Biomarkers for Older Controls at Risk for Dementia (BIOCARD) Study (U19)
  (NOT-AG-13-013)
  National Institute on Aging
  

• Notice of Correction to PHS 398 Research Plan Instructions Announced in PAR-13-147 Limited Competition: Dominantly Inherited Alzheimer Network (U19)
  (NOT-AG-13-014)
  National Institute on Aging
  

• Broad Agency Announcement (BAA): Large Scale T Cell Epitope Discovery BAA-NIAID-DAIT-NIH-AI-2013167
  (NOT-AI-13-047)
  National Institute of Allergy and Infectious Diseases
  

• Request for Proposals (RFP): Preclinical Development Services for AIDS Therapeutics RFP NIAID-DAIDS-NIH-AI-2013-170
  (NOT-AI-13-048)
  National Institute of Allergy and Infectious Diseases
  

• Notice of Intent to Publish a Funding Opportunity Announcement for NIDA Program Project Grant Applications (P01)
  (NOT-DA-13-028)
  National Institute on Drug Abuse
  

• Prize Competitions/Challenges in Area of Drug Abuse and Addiction
  (NOT-DA-13-029)
  National Institute on Drug Abuse
  

• Notice of Change to Funds Available and Anticipated Number of Awards for RFA-FD-13-016 In Vitro Release Tests for Topical Dermatological Products (U01)
  (NOT-FD-13-005)
  Food and Drug Administration
  

• Notice to Change Funds Available and Award Budget for RFA-FD-13-013 Systematic Evaluation of Excipient Effects on the Efficacy of Metered Dose Inhaler Products (U01)
  (NOT-FD-13-006)
  Food and Drug Administration
  

• Clarification of Rules for Program Directors/Principal Investigators on Sunsetting National Centers for Systems Biology
  (NOT-GM-13-120)
  National Institute of General Medical Sciences
  

• Notice of NICHD's Participation in RFA-NS-13-015 Pilot Projects on Sports-Related Brain and Spinal Cord Injury (R03)
  (NOT-HD-13-006)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Notice of NICHD's Participation in RFA-NS-13-014 Pilot Projects on Sports-Related Brain and Spinal Cord Injury (R21)
  (NOT-HD-13-007)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Notice of Change in Application Types Allowed for PAR-11-019 Centers Program for Research on HIV/AIDS and Mental Health (P30)
  (NOT-MH-13-016)
  National Institute of Mental Health
  

• Request for Information (RFI): Input on the Development of a Knowledge Management Center for the Illuminating the Druggable Genome Program
  (NOT-RM-13-018)
  Office of Strategic Coordination (Common Fund)
  

• Notice Announcing List of Genes of Interest to RFA-RM-13-003 Undiagnosed Diseases Gene Function Research (R21) will be Frequently Updated
  (NOT-RM-13-019)
  Office of Strategic Coordination (Common Fund)
  

• Innovative Approaches and Technologies for Examining the Uncultivable Bacteria of the Oral Microbiota (R01)
  (RFA-DE-14-003)
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): September 18, 2013
  

• United States Renal Data System (USRDS) Special Study Centers (U01)
  (RFA-DK-13-008)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): July 25, 2013
  

• In-vivo Methods for Assessing Placental Development and Function (R41/R42)
  (RFA-HD-14-004)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Biomedical Imaging and Bioengineering
  Application Receipt Date(s): August 21, 2013
  

• In-vivo Methods for Assessing Placental Development and Function (SBIR) (R43/R44)
  (RFA-HD-14-005)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Biomedical Imaging and Bioengineering
  Application Receipt Date(s): August 21, 2013
  

• Phenotyping Embryonic Lethal Knockout Mice (R01)
  (PAR-13-231)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Advancing Medical Device Postmarket Surveillance Infrastructure and Epidemiologic Methodologies through Multi-stakeholder Partnership (U01)
  (PAR-13-232)
  Food and Drug Administration
  Application Receipt Date(s): May 13, 2016 by 11:59 PM eastern Time. The original due date of April 29, 2016 is no longer valid.
  
  

  Past Tables of Contents

Department of Health and Human Services

National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892